The Boston Keratoprosthesis-The First 50 Years: Some Reminiscences
- PMID: 35834821
- DOI: 10.1146/annurev-vision-100820-021253
The Boston Keratoprosthesis-The First 50 Years: Some Reminiscences
Abstract
Millions of people worldwide are bilaterally blind due to corneal diseases including infectious etiologies, trauma, and chemical injuries. While corneal transplantation can successfully restore sight in many, corneal graft survival decreases in eyes with chronic inflammation and corneal vascularization. Additionally, the availability of donor cornea material can be limited, especially in underdeveloped countries where corneal blindness may also be highly prevalent. Development of methods to create and implant an artificial cornea (keratoprosthesis) may be the only option for patients whose eye disease is not suitable for corneal transplantation or who live in regions where corneal transplantation is not possible. The Boston Keratoprosthesis (B-KPro) is the most commonly implanted keratoprosthesis worldwide, having restored vision in thousands of patients. This article describes the initial design of the B-KPro and the modifications that have been made over many years. Additionally, some of the complications of surgical implantation and long-term care challenges, particularly complicating inflammation and glaucoma, are discussed.
Keywords: Boston KPro; Dohlman; autobiography; corneal blindness; corneal transplantation; keratoprosthesis.
Similar articles
-
Artificial Cornea Transplantation.2023 Apr 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Apr 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 33760451 Free Books & Documents.
-
Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.Acta Ophthalmol. 2023 Mar;101(2):242-243. doi: 10.1111/aos.15297. Acta Ophthalmol. 2023. PMID: 36794627
-
The Boston Keratoprosthesis in severe ocular trauma.Can J Ophthalmol. 2008 Apr;43(2):165-9. doi: 10.3129/i08-009. Can J Ophthalmol. 2008. PMID: 18347618
-
Challenges in management of the Boston Keratoprosthesis Type 1.Curr Opin Ophthalmol. 2021 Jul 1;32(4):385-388. doi: 10.1097/ICU.0000000000000774. Curr Opin Ophthalmol. 2021. PMID: 33973907 Review.
-
Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis.Cornea. 2019 Nov;38(11):1465-1473. doi: 10.1097/ICO.0000000000002098. Cornea. 2019. PMID: 31403526
Cited by
-
Clinical Outcomes of Stage 2 (Pivotal) Use of a Modified Keratoprosthesis Device (ORC-KPro) in Patients with End-stage Corneal Blindness.J Ophthalmic Vis Res. 2024 Sep 16;19(3):297-305. doi: 10.18502/jovr.v19i3.13307. eCollection 2024 Jul-Sep. J Ophthalmic Vis Res. 2024. PMID: 39359533 Free PMC article.
-
From waste to wealth: Repurposing slaughterhouse waste for xenotransplantation.Front Bioeng Biotechnol. 2023 Feb 3;11:1091554. doi: 10.3389/fbioe.2023.1091554. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36815880 Free PMC article.
-
Nanohydroxyapatite Coating Attenuates Fibrotic and Immune Responses to Promote Keratoprosthesis Biointegration in Advanced Ocular Surface Disorders.ACS Appl Mater Interfaces. 2024 May 22;16(20):25892-25908. doi: 10.1021/acsami.4c04077. Epub 2024 May 13. ACS Appl Mater Interfaces. 2024. PMID: 38740379 Free PMC article.
-
Visual outcomes of primary keratoprosthesis implantation in transplant-naïve eyes.PLoS One. 2024 Oct 3;19(10):e0311413. doi: 10.1371/journal.pone.0311413. eCollection 2024. PLoS One. 2024. PMID: 39361680 Free PMC article.
-
Outcomes of Boston Keratoprosthesis Type I Implantation in Poland: A Retrospective Study on 118 Patients.J Clin Med. 2024 Feb 8;13(4):975. doi: 10.3390/jcm13040975. J Clin Med. 2024. PMID: 38398288 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical